Pink SheetTwo US Food and Drug Administration advisory committees will consider whether industry-sponsored epidemiological studies of opioid analgesic misuse, abuse, overdose and death raise novel findings that
Pink SheetDrug and biologic product-related enforcement is expected to remain strong during the next Trump Administration, although the focus could shift compared to the Biden Administration. Imported ingredien
Medtech InsightPotential Nerve Damage Prompts Medtronic Recall Medtronic plc has issued a recall of a nerve monitoring system used to locate, monitor, and stimulate nerves of the skull, spine, and those that con
HBW InsightJohnson & Johnson ’s strategy to resolve class action complaints concerning talc-containing products could be short-circuited by a US Supreme Court ruling that opioid drug maker Purdue Pharma L.P. ’s